Oremepermin alfa
奥米普明 α
Report date: 2022/11/29 13:58:48
NME
Base Information
Drug NameOremepermin alfa
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesKringle PharmaNovelion Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesKringle Pharma Inc
Inactive CompaniesKringle Pharma Europe Ab
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A